Halozyme Therapeutics
HALO
$38.57
Share price
0.29%
Change (1 day)
17.38%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) - Cash on Hand
Cash on Hand as of December 2023 : $0.33 B
According to Halozyme Therapeutics's latest financial reports the company has $0.33 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.33 B | -7.39% |
| 2022-12-31 | $0.36 B | -51.03% |
| 2021-12-31 | $0.74 B | 101.33% |
| 2020-12-31 | $0.36 B | -12.64% |
| 2019-12-31 | $0.42 B | 18.82% |
| 2018-12-31 | $0.35 B | -24.44% |
| 2017-12-31 | $0.46 B | 128.91% |
| 2016-12-31 | $0.20 B | 89.2% |
| 2015-12-31 | $0.10 B | -20.12% |
| 2014-12-31 | $0.13 B | 89.67% |
| 2013-12-31 | $71.5 M | -28.14% |
| 2012-12-31 | $99.5 M | 88.36% |
| 2011-12-31 | $52.82 M | -36.55% |
| 2010-12-31 | $83.25 M | 23.41% |
| 2009-12-31 | $67.46 M | 5.88% |
| 2008-12-31 | $63.71 M | -34.77% |
| 2007-12-31 | $97.67 M | 121.05% |
| 2006-12-31 | $44.18 M | 130.97% |
| 2005-12-31 | $19.13 M | 19.52% |
| 2004-12-31 | $16 M | 3078.78% |
| 2003-12-31 | $0.5 M | 417.83% |
| 2002-12-31 | $0.09 M | 272.22% |
| 2001-12-31 | $0.02 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 6,723.51% | 🇺🇸 USA |
 Pfizer PFE | $12.69 B | 3,676.79% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | 771.34% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 2,854.80% | 🇫🇷 France |
 Baxter BAX | $3.19 B | 850.60% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.29 B | -12.17% | 🇺🇸 USA |